title: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.
authors.affiliation: American Urological Association Education and Research, Inc., USA. Craig.Hall@cornerstonehealthcare.com
authors.forename: M Craig
authors.initials: MC
authors.lastname: Hall
authors.forename: Sam S
authors.initials: SS
authors.lastname: Chang
authors.forename: Guido
authors.initials: G
authors.lastname: Dalbagni
authors.forename: Raj Som
authors.initials: RS
authors.lastname: Pruthi
authors.forename: John Derek
authors.initials: JD
authors.lastname: Seigne
authors.forename: Eila Curlee
authors.initials: EC
authors.lastname: Skinner
authors.forename: J Stuart
authors.initials: JS
authors.lastname: Wolf
authors.forename: Paul F
authors.initials: PF
authors.lastname: Schellhammer
mesh_terms: D000283:Administration, Intravesical; D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D015653:Cystectomy / Q000379:methods; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D018579:Patient Selection; D011379:Prognosis; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*
chemical_list: D001500:BCG Vaccine